ChatGPT SearchSep 26, 2026
Fayuvi (rebisufligene etisparvovec) became the first FDA-approved treatment for pediatric Sanfilippo syndrome type A in September 2026.
AI named Fayuvi in September 2026.
Question: What are the latest affordable advancements in biopharma for treating rare diseases?
ChatGPT SearchSep 26, 2026
Fayuvi (rebisufligene etisparvovec) became the first FDA-approved treatment for pediatric Sanfilippo syndrome type A in September 2026.
Brand page for fayuvi